RPH PHARMA LTD
Get an alert when RPH PHARMA LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-05-09 (in 1y)
Last made up 2026-04-25
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£1M
+116.9% highest in 6 filed years
Employees
5
Average over period
Profit before tax
£1M
+81.4% highest in 6 filed years
Net assets
6-year trend · vs Consumer Discretionary median
Accounts
6-year trend · latest reflected 2024-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | £1,087,992 | £1,002,103 | £989,173 | £1,930,346 | £2,872,988 | £13,533,970 | |
| Operating profit | £484,089 | £229,900 | £342,912 | £604,620 | £528,277 | £1,830,806 | |
| Profit before tax | £484,994 | £230,282 | £343,326 | £604,751 | £573,211 | £1,040,017 | |
| Net profit | £391,939 | £186,500 | £278,122 | £471,358 | £456,878 | £720,048 | |
| Cash | £929,268 | £1,011,784 | £328,809 | £970,669 | £480,795 | — | |
| Total assets less current liabilities | £973,147 | £1,159,647 | £337,769 | £159,127 | £616,005 | £1,336,053 | |
| Net assets | £973,147 | £1,159,647 | £337,769 | £159,127 | £616,005 | £1,336,053 | |
| Equity | £973,147 | £1,159,647 | £337,769 | £159,127 | £616,005 | £1,336,053 | |
| Average employees | — | 0 | — | — | — | 5 | |
| Wages | — | — | — | — | — | £461,758 | |
| Directors' remuneration | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+371.1%
£2,872,988 £13,533,970
highest in 6 filed years
-
Cash
—
Not reported
-
Net assets
+116.9%
£616,005 £1,336,053
highest in 6 filed years
-
Employees
—
Not reported
-
Operating profit
+246.6%
£528,277 £1,830,806
highest in 6 filed years
-
Profit before tax
+81.4%
£573,211 £1,040,017
highest in 6 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | 44.5% | 22.9% | 34.7% | 31.3% | 18.4% | 13.5% | |
| Net margin | 36.0% | 18.6% | 28.1% | 24.4% | 15.9% | 5.3% | |
| Return on capital employed | 49.7% | 19.8% | 101.5% | 380.0% | 85.8% | 137.0% | |
| Gearing (liabilities / total assets) | — | — | — | — | 0.0% | 0.0% | |
| Current ratio | — | — | — | — | 1.78x | 1.14x | |
| Interest cover | — | 1436.88x | — | — | — | 2.25x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- AGP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. The directors have reasonable expectation that the company has adequate resources to continue in operational existence for 12 months from signing. Accordingly, the directors continue to adopt the going concern basis in preparing the annual report and financial statements.”
Significant events
- “The principal activity of the company during the year was marketing the sale of pharmaceuticals. RPH Pharma Ltd (RPPL) changed its trading activity from the 01 April 2024 from acting as a commissionaire to becoming a sales and marketing company. It now owns the consignment stock that is sold through the 3PL Movianto. RPPL now invoices Movianto for the sale of consignment stock that is distributed to the Wholesalers within the UK. RPPL is now responsible for the inventory held at the 3PL.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHOUHAN, Kieran Charles | Director | 2023-09-01 | Jun 1985 | British |
| DAWSON, Andrew Robert Anthony | Director | 2023-02-01 | Jan 1980 | British |
| GRAND, Emmanuel Nicolas | Director | 2024-04-01 | Feb 1974 | Swiss |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HILAIRE, Jean-Francois | Director | 2018-07-16 | 2022-11-01 |
| HIRST, Christopher Anthony | Director | 2018-04-26 | 2024-04-01 |
| KAWALETZ, Gregor Johann | Director | 2024-04-01 | 2025-05-16 |
| KLUG, Oren | Director | 2022-05-11 | 2024-04-01 |
| LODGE, Lisa | Director | 2022-05-11 | 2023-02-01 |
| SPAK, Carl-Johan | Director | 2018-04-26 | 2018-07-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Eqt Ab (Publ) | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-02-15 | Active |
Filing timeline
Last 20 of 34 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-26 | AA | accounts | Accounts with accounts type full | |
| 2025-05-20 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-25 | AA | accounts | Accounts with accounts type full | |
| 2024-05-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-09 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-09 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-09 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-31 | AA | accounts | Accounts with accounts type full | |
| 2023-10-30 | AP01 | officers | Appoint person director company with name date | |
| 2023-04-28 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2023-04-28 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-04-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-02 | TM01 | officers | Termination director company with name termination date | |
| 2023-02-02 | AP01 | officers | Appoint person director company with name date | |
| 2022-12-16 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-12 | AA | accounts | Accounts with accounts type full | |
| 2022-05-27 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.